Elotuzumab API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Elotuzumab API 915296-00-3?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Elotuzumab. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Elotuzumab
- Cas Number:
- 915296-00-3
- DrugBank number:
- DB06317
- Unique Ingredient Identifier:
- 1351PE5UGS
About Elotuzumab
What makes Elotuzumab unique? Elotuzumab is a humanized IgG1 (Immunoglobulin G) monoclonal antibody indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies. Elotuzumab targets SLAMF7, also known as Signaling Lymphocytic Activation Molecule Family member a cell surface glycoprotein. Elotuzumab consists of the complementary determining regions (CDR) of the mouse antibody, MuLuc63, grafted onto human IgG1 heavy and kappa light chain frameworks. Elotuzumab is produced in NS0 cells by recombinant DNA technology.
Elotuzumab has a theoretical mass of 148. kDa for the intact antibody. Elotuzumab was approved on November 30, 2015 by the USA Food and Drug Administration. Elotuzumab is marketed under the brand Empliciti™ by Bristol-Myers Squibb.
Not sure if this is the exact product you're looking for? Contact the supplier by using the send inquiry button.
